HOME >> MEDICINE >> NEWS
Ovarian carcinoma, ethnicity, and survival

African-American women with ovarian carcinoma have a 30% greater risk of death from any cause and are more likely to die earlier when compared to Caucasian women with ovarian cancer. Findings in a recent study published in the March 15, 2002, issue of CANCER* indicate that ethnicity itself is a risk factor in ovarian cancer survival even after adjustment for prognostic factors that showed ethnic differences. Differences in prognostic factors were observed in age at diagnosis, marital status, stage of tumor, and site-specific surgical treatment.

Ovarian cancer causes more deaths per year than all other female reproductive cancers. Ethnicity, parity, oral contraception use, and breast feeding are all predictive factors for development of ovarian cancer. Factors that predict poor prognosis include higher disease stage and older age. Other studies have also shown that African-Americans with ovarian cancer have higher mortality rates than Caucasians with ovarian cancer. While ethnicity is a risk factor, little is known about the differences in prognostic factors between Caucasians and African-Americans with ovarian cancer that could effect survival. In a retrospective study of over 13,000 women with ovarian cancer, Barnholtz-Sloan et al analyzed data for differences in prognostic factors between Caucasians and African-Americans and the effect of these differences on ovarian cancer survival.

Data from 12,285 Caucasian women and 798 African-American women diagnosed with primary, malignant ovarian carcinoma was analyzed from the Surveillance, Epidemiology, and End Results (SEER) Program. SEER is a population-based national cancer surveillance database with demographic, clinical, treatment and survival information on men and women diagnosed with cancer. Factors included the database and analyzed in this study include marital status, age at diagnosis, tumor stage, tumor histology and grade, lymph node involvement, site-specific surgical treatment, and
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
212-850-6484
John Wiley & Sons, Inc.
14-Mar-2002


Page: 1 2

Related medicine news :

1. Ovarian cancer does have early warning signs, Mayo Clinic and Olmsted Medical Center find
2. Ovarian cancer rates across Europe
3. Ovarian tissue storage and later transplant shows promise for women infertile from cancer therapy
4. Ovarian Hormone Could Play Key Role In Easier, Safer Childbirth
5. Age, ethnicity, income impact exercise habits of elderly
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. Lack of clinical trial participation may contribute to lower survival rates
8. Alcohol relapse adversely affects 10-year liver transplant survival
9. Donor age has no affect on long-term liver transplant survival
10. Specialist care gives better rate of survival
11. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ovarian carcinoma ethnicity and survival

(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied ... Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress yesterday ... (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web Marketing ... All-Stars Summit. Google Partners is the platform for search marketing agencies to communicate ... and tools necessary to run successful search marketing campaigns. Google Partners also affords ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has officially been accredited by ... recommendations.” No recommendations means CARF found no areas in the OHR program that needed ... 3% of all facilities receive. In addition, Ocean Hills was granted the maximum certification ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... of Medicine at Mount Sinai Earns National Cancer Institute Designation , The Tisch ... been named a National Cancer Institute (NCI)-designated cancer center. TCI joins an elite ...
(Date:7/30/2015)... ... July 30, 2015 , ... 1Heart Caregiver Services LLC is offering its ... Make Money in the Booming Homecare Business.” This will be held in its main ... , The event will be hosted by 1Heart’s very own Randy Clarito (Director of ...
Breaking Medicine News(10 mins):Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2
(Date:7/30/2015)... 30, 2015  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, today ... year 2015 financial results after the market close on ... follow on the same day at 4:30 p.m. ET. ... Chief Executive Officer, and Rick Eiswirth , Chief ...
(Date:7/30/2015)... , Net Sales of $1.17 billion represent a decrease of ... of 5.7% constant currency , Reported net loss per ... per share were $1.59, an increase of 0.6% over the ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ...  The Company reported second quarter net sales of $1.17 billion, ...
(Date:7/29/2015)... Ill. , July 30, 2015  Astellas ... ACTIVE study evaluating the efficacy and safety of ... CRESEMBA® (isavuconazonium sulfate), under development for adults with ... Results from the study demonstrated that the trial ... in overall treatment response in isavuconazole-treated patients at ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5
Cached News: